Form 4: Broadwood Partners, L.P. Increases Stake in STAAR Surgical Co.
SEC Form 4 Filing
Broadwood Partners, L.P. has increased its holdings in STAAR Surgical Co. through a series of open market purchases.
Summary
- Broadwood Partners, L.P., along with related entities, has reported several transactions involving the purchase of STAAR Surgical Co. common stock.
- These transactions occurred between December 16, 2024, and December 18, 2024.
- The purchases were made at varying weighted average prices, ranging from $23.73 to $24.89 per share.
- The total number of shares beneficially owned by Broadwood Partners, L.P. after these transactions is 10,848,631.
- Neal C. Bradsher also directly owns 25,900 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive as it indicates a major shareholder is increasing their position, which is generally seen as a positive sign, but it is a routine filing.
Positives
- Broadwood Partners, L.P. has increased its investment in STAAR Surgical Co., indicating confidence in the company's future prospects.
- The purchases were made at varying prices, suggesting a strategic approach to accumulating shares.
Risks
- The document does not explicitly state any risks, but the increased ownership by Broadwood Partners, L.P. could potentially lead to increased influence over the company's direction.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in the public markets. It indicates that a major shareholder is increasing their position in the company.
Comparison to Industry Standards
- Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders in publicly traded companies.
- The reported transactions are typical for institutional investors adjusting their positions.
- The level of detail provided in the filing is consistent with SEC requirements.
Stakeholder Impact
- The increased ownership by Broadwood Partners, L.P. could be viewed positively by shareholders, potentially increasing confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Broadwood Partners, L.P. purchased 46,220 shares at a weighted average price of $24.1523 and 7,280 shares at a weighted average price of $24.8303. |
| 12/17/2024 | Broadwood Partners, L.P. purchased 3,700 shares at a weighted average price of $24.5845. |
| 12/18/2024 | Broadwood Partners, L.P. purchased 23,000 shares at a weighted average price of $24.3258. The form was also signed and dated. |
Keywords
STAAR Surgical, Broadwood Partners, stock purchase, beneficial ownership, SEC Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.